Stock Comparison
ARGX vs CORT
argenx NV ADR and Corcept Therapeutics Incorporated side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$53.23B
$11.58B
P/E (TTM)
32.7
238.1
Forward P/E
30.4
54.4
Price/Sales
10.0
13.9
Price/Book
6.4
16.4
EV/EBITDA
27.6
1,274.7
Dividend Yield
—
—
Profitability
Net Margin
30.44%
6.61%
Operating Margin
27.34%
0.77%
Return on Equity
23.60%
8.23%
Return on Assets
11.60%
0.47%
Growth (YoY)
Revenue Growth
59.30%
31.70%
Earnings Growth
95.20%
24.10%
Price & Risk
Beta
-0.0
0.5
52-Week High
$939.68
$118.32
52-Week Low
$652.43
$32.15
Analyst Target
$1,085.78
$135.25
Compare ARGX and CORT your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.